ABOUT THIS EVENT

CureVac AG (Nasdaq:CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), rang the Nasdaq Closing Bell remotely from across the country.

Dr. Franz-Werner Haas, Chief Executive Officer, rang the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.